Showing 1–24 of 32 peptides in Weight Loss
A metabolic modulator studied for fat metabolism.
- Weight Loss
- Anti-Aging
- Gut Health
A research peptide investigated for metabolic and body-composition support.
A targeted peptide researched for fat reduction.
- Targets blood vessels of white adipose tissue in preclinical fat‑loss models
- May reduce fat mass by promoting apoptosis of adipose vasculature
- Investigated for body‑weight reduction and metabolic risk modulation
A metabolic peptide researched for endurance and fat oxidation.
- Activates AMPK to support metabolic regulation in research models
- May enhance glucose uptake and insulin sensitivity in skeletal muscle
- Investigated for promoting fatty acid oxidation and reducing adiposity
- Weight Loss
- Muscle Recovery
A fragment peptide researched for fat loss.
- Mimics the fat‑metabolism fragment of human growth hormone without full GH activity
- Supports lipolysis and may reduce abdominal and visceral fat in studies
- Investigated for joint and cartilage support alongside weight‑management effects
An amylin analog researched for appetite control.
- Long-acting amylin analog studied for significant body‑weight reduction
- Supports appetite control and enhanced satiety through delayed gastric emptying
- Investigated for improved glycemic control and broader cardiometabolic markers
- Muscle Recovery
- Weight Loss
- +1
A growth hormone releasing peptide studied for longevity and recovery.
- GHRH analog studied for increasing endogenous growth hormone and IGF-1 levels
- May support muscle growth, fat loss, and recovery when combined with training
- Investigated for improved sleep quality and general anabolic support
- Muscle Recovery
- Weight Loss
- +1
A long-acting GHRH analog for sustained GH release.
- Long-acting GHRH analog researched for sustained growth hormone elevation
- May enhance muscle mass, recovery, and body composition in study settings
- Investigated for convenience of less frequent dosing while maintaining GH pulses
- Muscle Recovery
- Weight Loss
- +1
A short-acting GHRH analog that enhances natural GH pulses.
- Shorter-acting GHRH analog studied for more physiologic GH pulse support
- May aid muscle repair, strength, and lean mass accrual in research protocols
- Investigated for synergistic use with GHRP‑class secretagogues
- Muscle Recovery
- Weight Loss
A myostatin-binding protein studied for muscle growth.
- Variant of follistatin studied for potent myostatin and activin inhibition
- May enhance lean muscle mass and reduce adiposity in animal models
- Investigated for regenerative and performance‑oriented muscle support
- Muscle Recovery
- Weight Loss
- +1
The primary hormone regulating growth hormone release.
- Endogenous hormone analog studied for stimulating growth hormone secretion
- May support lean mass, recovery, and metabolic health when GH is deficient
- Investigated for broader endocrine balance within the GH–IGF‑1 axis
- Muscle Recovery
- Weight Loss
A potent growth hormone releasing peptide.
- Growth hormone secretagogue researched for strong GH pulse stimulation
- May enhance muscle recovery, strength, and body‑composition changes
- Investigated for synergistic use with GHRH analogs in GH‑deficient models
- Muscle Recovery
- Weight Loss
A potent growth hormone secretagogue with appetite-stimulating effects.
- Potently stimulates growth hormone release via ghrelin receptor activation
- Supports muscle growth, strength, and recovery in research settings
- May increase appetite and enhance nutrient partitioning toward lean tissue
- Muscle Recovery
- Weight Loss
A powerful growth hormone releasing peptide with anabolic potential.
- Growth hormone secretagogue studied for strong GH and IGF‑1 elevation
- May support muscle mass, bone density, and recovery after intense training
- Investigated for potential cardioprotective and metabolic effects in models
A growth hormone fragment researched for selective fat loss.
- C‑terminal fragment of GH researched for selective stimulation of lipolysis
- May reduce abdominal and overall body fat with minimal impact on blood glucose
- Investigated for body‑composition management separate from full GH actions
- Muscle Recovery
- Weight Loss
- +1
A selective growth hormone secretagogue peptide.
- Selective ghrelin mimetic studied for targeted GH release with fewer off‑target hormones
- May support muscle repair, fat loss, and improved recovery after training
- Investigated for synergistic use with GHRH analogs for physiologic GH pulsing
A GLP-1 receptor agonist studied for metabolic regulation.
- GLP‑1 receptor agonist studied for significant body‑weight reduction in obesity
- Improves glycemic control by enhancing insulin secretion and reducing glucagon
- May lower cardiometabolic risk markers such as blood pressure and lipids in trials
- Skin, Hair & Beauty
- Weight Loss
A peptide studied for pigmentation and photoprotection.
- Alpha‑MSH analog studied for increasing skin pigmentation and photoprotection
- May help reduce sunburn risk by darkening skin through melanocortin receptor activation
- Investigated for potential effects on appetite and inflammation via melanocortin pathways
- Sexual Health
- Skin, Hair & Beauty
- +1
A melanocortin peptide researched for tanning and libido effects.
- Melanocortin analog researched for tanning and libido‑modulating effects
- May enhance sexual arousal and erectile function through central melanocortin signaling
- Investigated for appetite suppression and body‑weight modulation
- Muscle Recovery
- Sleep & Mood
- +1
An oral growth hormone secretagogue studied for GH stimulation.
- Oral growth hormone secretagogue researched for raising GH and IGF-1 levels
- May support increases in lean body mass, strength, and bone density in studies
- Investigated for enhancing sleep quality, recovery, and overall body composition
A mitochondrial peptide researched for metabolic health.
- Mitochondria-derived peptide researched for improving insulin sensitivity and glucose handling
- May enhance mitochondrial respiration and protect against metabolic and cardiac dysfunction
- Investigated for reducing weight gain and age-related metabolic decline in models
An oral non-peptide GLP-1 receptor agonist researched for obesity and diabetes.
A bioregulatory peptide researched for pancreatic support.
- Pancreatic bioregulatory peptide studied for supporting insulin and glucagon regulation
- May enhance pancreatic cell repair, enzyme production, and digestive efficiency
- Investigated for improving blood sugar control and metabolic health with aging
A multi-receptor incretin agonist studied for metabolic control.
- Triple agonist of GLP‑1, GIP, and glucagon receptors studied for substantial weight loss
- May provide robust reductions in HbA1c and improvements in liver and cardiometabolic markers
- Investigated for obesity, type 2 diabetes, NASH, and related metabolic diseases